newsfilter
← Latest News
GlobeNewswire·

Outlook Therapeutics Expands Commercial Team with Appointment of Senior Vice President of Commercial Operations

Joel Prieve brings nearly 20 years of commercial operations expertise and proven track record in sales and account management ISELIN, N.J., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company